Recent studies have further revealed that MARVELD2 is frequently overexpressed in hepatocellular carcinoma cells but downregulated in pancreatic carcinomas cells (Kojima and Sawada, 2012; Korompay et al., 2012; Somoracz et al., 2014). The gene discussed is MARVELD2; the disease is hepatocellular carcinoma.